Biomarker sets predict response to TNFi
| Biomarker sets | Metrological properties, % | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| S100A8/A9 | S100A12 | PF4 | Apo A1 | Pre albumin | α1 AT | Hapto | Se | Sp | PPV | NPV | |
| RA male ETN | – | – | – | X | X | – | – | 80 | 100 | 100 | 89 |
| RA female ETN | X | – | X | – | X | – | – | 100 | 100 | 100 | 100 |
| RA male ADA | – | X | – | – | – | – | – | 100 | 100 | 100 | 100 |
| SpA male ETN | X | – | X | X | – | X | – | 80 | 96 | 89 | 92 |
| SpA female ETN | X | – | – | X | X | – | – | 100 | 92 | 75 | 100 |
| SpA male ADA | – | X | – | X | – | – | – | 100 | 97 | 67 | 100 |
| SpA male IFX | X | X | X | – | – | – | – | 80 | 100 | 100 | 97 |